Clare Gaduzo BSc RMN Registered Aesthetics Practitioner (qualified with Medics Direct)

Similar documents
BOTOX (onabotulinumtoxina) for Therapeutic Use

THE CLINICAL USE OF BOTULINUM TOXIN IN THE TREATMENT OF MOVEMENT DISORDERS, SPASTICITY, AND SOFT TISSUE PAIN

Botox , The Patient Education Institute, Inc. rxf60101 Last reviewed: 01/11/2018 1

Informed Consent Form

Botox. Botox (onabotulinum toxin A) Description

MEDICATION GUIDE BOTOX BOTOX Cosmetic (Boe-tox) (onabotulinumtoxina) for Injection

BOTOX. Description. Section: Prescription Drugs Effective Date: January 1, 2013 Subsection: CNS Original Policy Date: December 7, 2011

Headache and Migraine Treatment

BOTULINUM TOXIN POLICY TO INCLUDE:

Policy. Medical Policy Manual Approved Revised: Do Not Implement Until 4/2/19. IncobotulinumtoxinA

CONSUMER MEDICINE INFORMATION

Neuromuscular Blocking Agents

Disclaimer. All information shared in this presentation is in the public domain.

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?

ALTERNATIVE TREATMENTS

(ONABOTULINUMTOXINA) RECEIVES U.S

Botox. Botox (onabotulinum toxin A) Description

This policy addresses only the type B formulation rimabotulinumtoxinb marketed as Myobloc.

CONSUMER MEDICINE INFORMATION

What it looks like 2. WHAT BOTOX INJECTION IS USED FOR. How BOTOX injection works

Prof. of Neurology, Cairo University Vice President of the Egyptian Society of Neurology, Secretary General of Pan Arab union of Neurological

Botulinum Toxin

CONSUMER MEDICINE INFORMATION

Scientific Update Laxman Bahroo, MD

Botox (onabotulinumtoxina) Dysport (abobotulinumtoxina) Xeomin (incobotulinumtoxina) Myobloc (rimabotulinumtoxinb)

Scottish Medicines Consortium

Informed Consent Botulina Toxins Botox, Dysport, Xeomin Neurotoxins

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

NAME OF THE MEDICINE BOTOX purified neurotoxin complex injection (50U, 100 U or 200 U) (botulinum toxin, type A) DESCRIPTION Composition

M0BCore Safety Profile

Circle Yes or No Y N. [If yes, no further questions.]

DYSPORT (Clostridium botulinum type A toxin-haemagglutinin complex)

Treatment of facial palsy with Botulinum Toxin (Botox) Information for patients

Prior Authorization Update: Botulinum Toxins

DYSPORT (Clostridium botulinum type A toxin-haemagglutinin complex)

Dr. F Didar CEO Cosmetic Facial UK(CFUK) Limited

BOTOX Cosmetic (onabotulinumtoxina) before-and-after

200 SW 8 th St, STE A, Ocala, FL PH: FAX: Dr. Omar Garcia, Medical Director

Why is this botulinum toxin prescribed?

Botulinum toxin A (Dysport) for hyperhidrosis of the axillae

BOTOX Cosmetic (onabotulinumtoxina) before-and-after photo files

Frequently Asked Questions

This guide describes some of the important facts about Neurobloc that you need to be aware of, however, it does not replace the advice given to you

Clinical Policy: IncobotulinumtoxinA (Xeomin) Reference Number: CP.PHAR.231

Albert C. Clairmont, MD Associate Professor-Clinical Department of PM & R The Ohio State University

NAME OF THE MEDICINE. BOTOX purified neurotoxin complex injection (100 U or 200 U) (botulinum toxin, type A) DESCRIPTION.

Botox (onabotulinumtoxina) Dysport (abobotulinumtoxina) Xeomin (incobotulinumtoxina) Myobloc (rimabotulinumtoxinb)

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?

Clinical Policy: IncobotulinumtoxinA (Xeomin) Reference Number: ERX.SPA.194 Effective Date:

USE OF BOTOX IN THE CHILD WITH CEREBRAL PALSY. Andrew Redfern Senior Registrar, Paed Neurodevelopment Red Cross Children s Hospital

See Important Reminder at the end of this policy for important regulatory and legal information.

INFORMED CONSENT BOTOX INJECTION

Botulinum toxins: abobotulinumtoxina (Dysport ), incobotulinumtoxina (Xeomin ), onabotulinumtoxina (Botox ), & rimabotulinumtoxinb (Myobloc )

Botulinum Toxins. Length of Authorization: From 90 days to 12 months

Treatment of Facial Palsy with Botulinum Toxin (Botox)

Botox for chronic migraine. Information for patients Neurology

Botulinum Toxin Application

DYSrupt Your Patients Spasticity Symptoms

Treatment Framework patient tracker

Table of Contents. 1.0 Description of the Procedure, Product, or Service Safety and Provider Compliance... 1

Medication Prior Authorization Form

General discussion about the last lecture:

See Important Reminder at the end of this policy for important regulatory and legal information.

Parkinson's Disease Center and Movement Disorders Clinic

See Important Reminder at the end of this policy for important regulatory and legal information.

HASPI Medical Anatomy & Physiology 09b Lab Activity

Elements of Provider Documentation Consistent with Medicare Guidelines

This policy addresses only the type A formulation abobotulinumtoxina marketed as Dysport.

Abbreviated Class Review: Botulinum toxins

Overview of Botulinum Toxin

The Truth About Botox

Ch.10 Muscle Tissue. Copyright 2009, John Wiley & Sons, Inc.

INFORMED CONSENT BOTULINA TOXINS - BOTOX INJECTION

Fight spasticity with everything you ve got Let s talk about BOTOX

ASPIRE INFORMED CONSENT DOCUMENT

Botulinum Toxin Injections

Medication Prior Authorization Form

Botox Approval Process Orange County Migraine & Headache Center

WARNING: DISTANT SPREAD OF TOXIN EFFECT

[If yes, no further questions.]

BOTULINUM TOXIN AND INTRATHECAL BACLOFEN. Spencer Cotterell DO Mercy Rehabilitation Hospital June 30, 2018

See Important Reminder at the end of this policy for important regulatory and legal information.

MYOBLOC and Cervical Dystonia A Patient s Guide

Please see Approved Uses and Important Safety Information, including Boxed Warning, inside.

GCE A level 1074/02 HUMAN BIOLOGY HB4

See Important Reminder at the end of this policy for important regulatory and legal information.

Philadelphia College of Osteopathic Medicine. Victoria J. Kopec Philadelphia College of Osteopathic Medicine,

Botulinum Toxin: Applications in Urology

Your Spasticity Management Service: Managing spasticity with Botulinum Toxin A in children with cerebral palsy

Understanding Dystonia

Package leaflet: Information for the user

INSTRUCTIONS INTRODUCTION RISKS OF BOTULINUM TOXIN / DERMAL FILLER INJECTIONS

Intravesical Botox Injections

Dystonias. How are the dystonias classified? One way of classifying the dystonias is according to the parts of the body they affect:

Aetna Better Health of Virginia

NERVOUS SYSTEM NERVOUS SYSTEM. Somatic nervous system. Brain Spinal Cord Autonomic nervous system. Sympathetic nervous system

Dystonia. The condition can vary from very mild to severe. Dystonia may get worse over time or it may stay the same or get better.

Summary. Neuro-urodynamics. The bladder cycle. and voiding. 14/12/2015. Neural control of the LUT Initial assessment Urodynamics

Transcription:

Clare Gaduzo BSc RMN Registered Aesthetics Practitioner (qualified with Medics Direct) 07935567067 cjg.aesthetics@yahoo.co.uk www.cjgaesthetics.co.uk http://www.facebook.com/cjgaesthetics @CJGAesthetics BOTOX Wrinkle Correction Botox An advanced and effective treatment to smooth fine lines and wrinkles giving the skin a rejuvenated and youthful appearance. Botulinum toxin A is injected to relax the muscles under the skin, to lift brows, relax frown lines and crows feet. Botox to prevent Migraines The muscle-relaxing injections are popular as a cosmetic treatment but, due to its nerve-blocking effects, Botox also has a role in treating certain medical conditions. The move to use Botox to prevent migraines is based on new guidance published by the National Institute for Health and Clinical Excellence (NICE). NICE recommends that Botox can be considered as an option for the prevention of headaches for people who have chronic migraine (headaches on at least 15 days of every month, at least eight days of which are migraine) that has not responded to at least three prior preventative drug treatments. Botox hyperhidrosis treatment (excessive sweating) Botox (Botulinum toxin A) is injected into the skin to treat the symptoms of severe underarm sweating (severe primary axillary hyperhidrosis) when medicines used on the skin (topical) do not work well enough in people 18 years and older. Treatment is available for palms, underarms, and face & forehead excessive sweating. The Botox binds to the nerves that control sweating in the skin, and reduces sweating in the area for 4-6 months without having compensatory effects. Clinical studies have shown that this treatment reduces the amount of sweating by 75-80%. A course usually lasts 4-6 months. In order to ensure you obtain the best results CJG administer only Botox at strong therapeutic levels. CJG AESTHETIC, Telephone: 07935567067 Botox, Page 1 of 6

APPROVED THERAPEUTIC INDICATIONS FOR BOTOX Blepharospasm: Patients suffering from the condition experience an involuntary clenching of the muscles that control the eyelids, causing uncontrollable blinking which generally affects both eyes. Blepharospasm can diminish a patient's ability to perform everyday activities by interfering with their ability to see due to the lid blocking their vision. This can progress from increased blinking to inability to open the eyelids, and finally, to functional blindness. Blepharospasm affects an estimated 20,000 50,000 people in the UK, with 2,000 new cases diagnosed annually. Therapy with Botox is a recognized treatment for blepharospasm, and involves the injection of small therapeutic doses directly in the affected muscles around the eye to temporarily reduce the excessive muscle contractions. Cervical Dystonia Cervical dystonia, also called chronic spasmodic torticollis, is a painful neurological disorder. Cervical dystonia is a type of movement disorder conditions that are characterized by loss of control in the neck area, which is estimated to affect approximately 125,000 people in the UK, yet awareness of the condition is extremely limited. Cervical dystonia is characterised by involuntary contractions of the neck muscles that cause twisting, repetitive movements, or abnormal postures of the head. The mean age of symptom onset in patients with cervical dystonia is approximately 41 years although it may occur in all ages and women are twice as likely to be affected as men. Botox (botulinum toxin A) has been approved for the treatment of the abnormal head position and neck pain that happens with cervical dystonia (CD) in people 16 years and older. Chronic Migraine Chronic Migraine is a distinct and severe neurological disorder impacting an estimated 3.2 million people and characterised by patients who have a history of migraine and suffer from headaches for consecutive days. Botox is approved by the NICE guidelines. Although Chronic Migraine occurs in both men and women, women are three times more likely than men to be affected. Sufferers often experience depression and anxiety as part of the condition. Chronic Migraine also can be influenced by life stress, sleep habits, diet and overuse of acute medications that relieve pain associated with symptoms of headache. Severe Primary Axillary Hyperhidrosis Hyperhidrosis is the medical term for severe sweating, where patients may sweat up to four or five times more than normal, far exceeding what is needed to regulate body temperature. Severe underarm sweating may be exacerbated by stress, emotion or exercise, but often occurs spontaneously. BOTOX The effects of treatment are temporary, lasting approximately 6-7 months, and treatment is often covered by insurance. BOTOX is also injected into the skin to treat the symptoms of severe underarm sweating (severe primary axillary hyperhidrosis) when medicines used on the skin (topical) do not work well enough in people 18 years and older. Strabismus Strabismus is a visual defect that results when the eyes do not properly align with each other. One eye may look straight ahead but the other may turn in ( crossed eyes ), out ( wall eyes ), upward, or downward. Strabismus usually develops during childhood but can occur at any age, affecting nearly four in every 100 adults. Therapy with BOTOX involves the injection of small therapeutic doses of purified botulinum toxin protein directly into the muscles surrounding the eye. CJG AESTHETIC, Telephone: 07935567067 Botox, Page 2 of 6

Limb Spasticity Spasticity is a debilitating condition, caused by spasm of muscles in the upper or lower limbs following a stroke. Upper limb spasticity may also occur following traumatic spinal cord or brain injury or in patients affected by multiple sclerosis or adults with a history of cerebral palsy. Although not a life-threatening condition, upper limb spasticity can be debilitating, producing muscle contractions that can result in stiff, tight muscles in the elbow, wrist and fingers, or a clenched fist. This stiffness hinders a patient s ability to perform simple tasks, such as dressing or washing the hand, and often leaves the patient dependent on a carer to help with simple activities. In patients diagnosed with upper limb spasticity, Botox is injected by a trained specialist directly into the affected muscles blocking overactive nerve impulses that trigger these contractions to reduce the severity of increased muscle tone in the elbow, wrist and fingers. In clinical studies, the efficacy of Botox persisted up to three months on average. Treatment with Botox is not meant to replace your existing physical therapy or rehabilitation that your doctor may have prescribed. Urinary Incontinence Urinary incontinence due to detrusor over-activity associated with a neurologic condition, such as multiple sclerosis (MS) or spinal cord injury (SCI), results when the spinal cord and bladder do not communicate effectively. For people living with MS, this occurs because they develop lesions on the spinal cord, while people with SCI have irreversible nerve damage, resulting in the inability of the spinal cord and bladder to communicate effectively. As a result, the bladder muscle involuntarily contracts, increasing the pressure in the bladder and decreasing the volume of urine the bladder can hold, which causes the individual to leak urine frequently and unexpectedly. More than half of patients with MS, SCI, Parkinson s disease or stroke may have overactive bladder. Botox has been approved for injection into muscles for the treatment of leakage of urine (incontinence) in adults with overactive bladder due to neurologic disease (e.g. multiple sclerosis (MS) or spinal cord injury (SCI)) who still have leakage or experience too many side effects after trying an anti-cholinergic medication in people 18 years and older. Physiology and Pharmacology of BOTOX Botulinum Toxin is a neurotoxin made by the bacteria Clostridium Botulinum, a rod shaped anaerobic bacterium found in soil, which can causes a severe form of food poisoning. Botulinum Toxin is purified for clinical use. Botox is a formulation of Botulinum Toxin type A produced by Allergen, lnc. Botox is a 900kD complex containing Type A neurotoxin and associated proteins. There are 7 separate serotypes of Botulinum Toxin. These serotypes differ in potency and duration of effect. Botulinum Toxin Type A is the most potent of the serotypes and therefore is used for clinical and aesthetic uses. lt is a di-chain polypeptide molecule; it consists of two chains - a light chain (SOkD) and a heavy chain. Mechanism of action of Botox Botox is injected intramuscularly. It works by inhibiting the release of the neurotransmitter acetylcholine from motor nerve terminals. This is a form of chemical denervation. The mechanism of action of Botox can be divided in to 4 stages: Stage 1 Binding Figure 1. Post injection Botox binds to special receptors on the external Membranes of motor cholinergic neurons via the heavy chain. CJG AESTHETIC, Telephone: 07935567067 Botox, Page 3 of 6

Stage 2 lnternalisation Figure 2. Botox is now internalised by a process called endocytosis. Botox then forms a vesicle inside the motor-neurone terminal. The light chain of the molecule is then released on to the cytoplasm of the Cell. Stage 4 Re-establishment of neuromuscular transmission Figure 4: Botox prevents affected terminals from stimulating muscle contraction' the synthesis and storage of acetylcholine or the conduction of the electrical signals is unaffected. Evidence indicates that chemo enervation by Botox results in growth of the end plate region and the emergence of axonal sprouts. These sprouts may begin to release Acetylcholine. Stage 3 Blocking Figure 3' while in the cytoplasm the light chain splits one of the proteins which is needed to form, which {snart complex) is responsible for exocytose of the vesicles containing acetytcholine. Acetylcholine is therefore not released and muscle contraction is inhibited. Figure 5: The development of a new neuromuscular junction means that muscle activity resumes usually after about three months, repeated injections are thus required to maintain therapeutic effects. Eventually, the original junction resumes activity, and sprouts regress. CJG AESTHETIC, Telephone: 07935567067 Botox, Page 4 of 6

This diagram shows where you can use BOTOX For further information on Botox please follow this link: http://www.botox.com CJG AESTHETIC, Telephone: 07935567067 Botox, Page 5 of 6

Diagram of the Musculature of the Face CJG AESTHETIC, Telephone: 07935567067 Botox, Page 6 of 6